Biologic Drugs

May 23, 2018
By Pharmaceutical Technology Editors
The new company will develop proprietary RNA-based therapeutics and will provide broad lentiviral development and manufacturing expertise and support.
May 16, 2018
By Pharmaceutical Technology Editors
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
May 16, 2018
By Pharmaceutical Technology Editors
The company is increasing its cell culture media production capacity at its facilities in Pasching, Austria, and Logan, Utah.
May 15, 2018
Pharmaceutical Technology
Naturally occurring and engineered albumins are being explored as a tool to enhance the stability of drugs, including biologics, and extend shelf-life.
May 15, 2018
Pharmaceutical Technology
Understanding the advantages and suitability of different methods to measure residual moisture content in lyophilized materials--and the respective limitations--aids in selecting the most appropriate method for testing.
May 02, 2018
Pharmaceutical Technology
Bioprocess understanding, the right equipment, and automation help, but multifunctional teamwork is the key to API production success.
May 02, 2018
Pharmaceutical Technology
A skilled workforce is needed to deliver on technology’s promising medical advances.
Apr 30, 2018
By Pharmaceutical Technology Editors
After a review of public comments, USP will not move forward with nomenclature proposal without further FDA collaboration.
Apr 20, 2018
By Pharmaceutical Technology Editors
The new platform is expected to speed up cell line development.
Apr 19, 2018
By Pharmaceutical Technology Editors
The agency has granted breakthrough therapy designation to Roche’s hemophilia therapy for treating hemophilia A in patients without factor VIII inhibitors.
native1_300x100
lorem ipsum